Skip to content
StockMarketAgent
Healthcare / Pharmaceutical RetailersUpdated 2026-05-10 22:07 UTC

TPEX/4175 stock hub

TPEX/4175 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

TPEX/4175is not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
2.3B
Taipei Exchange
Market data

Live price

Current market quote for this ticker.

Current price
TPEX/4175
In the news

Latest news · TPEX/4175

Recent company headlines from major financial publishers.

Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window
EPS estimate
Revenue estimate
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a
P25 12P50 15.5P75 22.5
Trailing P/E14.8
P25 14.4P50 18P75 31.9
ROE10.3
P25 -16.2P50 0.3P75 9.8
ROIC3.7
P25 -11.7P50 -0.2P75 8.8
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All TPEX/4175 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
235
Groups with data
11
Currency
TWD
Showing 235 of 235 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

16
MetricValue
Country
Taiwan
Country code
TW
Enterprise value
TWD 5.4B
Exchange
Taipei Exchange
Financial currency
TWD
First seen
2026-05-10
Industry
Pharmaceutical Retailers
Isin
TW0004175005
Last refreshed
2026-05-10
Market cap
TWD 2.3B
Price
TWD 53.9
Price currency
TWD
Sector
Healthcare
Sic
5912
Symbol
tpex/4175
Website
https://www.medfirst.com.tw

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

13
MetricValue
Earnings Yield
6.82%
EV Earnings
34.49x
EV/EBIT
25.44x
EV/EBITDA
5.43x
EV/FCF
8.59x
EV/Sales
0.67x
FCF yield
27.38%
P/B ratio
1.46x
P/E ratio
14.81x
P/S ratio
0.28x
PE Ratio10 Y
33.91x
PE Ratio3 Y
65.77x
PE Ratio5 Y
49.65x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

25
MetricValue
EBIT Margin
2.63%
EBITDA Margin
4.96%
FCF margin
7.79%
Gross margin
32.46%
Gross Profit
TWD 2.6B
Gross Profit Growth
9.15%
Gross Profit Growth Q
5.24%
Gross Profit Growth3 Y
5.64%
Gross Profit Growth5 Y
7.35%
Net Income
TWD 155.5M
Net Income Growth
122.79%
Net Income Growth Q
-12.64%
Net Income Growth Years
2%
Net Income Growth3 Y
-3.08%
Net Income Growth5 Y
7.2%
Pretax Margin
2.33%
Profit Margin
1.94%
Profitable Years
7
ROA
1.83
Roa5y
1.38
ROCE
4.63
ROE
10.27
Roe5y
7.61
ROIC
3.74
Roic5y
3

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

27
MetricValue
Cagr10y
1.07%
Cagr1y
-15.59%
Cagr3y
-21.22%
Cagr5y
-0.4%
Div CAGR10
-4.55%
Div CAGR3
-21.17%
Div CAGR5
-12.09%
EPS Growth
120.8
EPS Growth Q
-14
EPS Growth Years
2
EPS Growth3 Y
-3.85
EPS Growth5 Y
5.7
FCF Growth
53.34%
FCF Growth Q
6.3%
FCF Growth3 Y
-7.14%
FCF Growth5 Y
43.77%
OCF Growth
66.71%
OCF Growth Q
4.97%
OCF Growth10 Y
20.19%
OCF Growth3 Y
-5.46%
OCF Growth5 Y
10.34%
Revenue Growth
3.6x
Revenue Growth Q
3.29x
Revenue Growth Quarters
9x
Revenue Growth Years
6x
Revenue Growth3 Y
3.51x
Revenue Growth5 Y
6.21x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

22
MetricValue
Asset Turnover
TWD 1.11
Assets
TWD 7.3B
Cash
TWD 504.6M
Current Assets
TWD 2.3B
Current Liabilities
TWD 2.7B
Debt
TWD 3.6B
Debt EBITDA
TWD 3.63
Debt Equity
TWD 2.29
Debt FCF
TWD 5.74
Equity
TWD 1.6B
Interest Coverage
3.44
Liabilities
TWD 5.7B
Long Term Assets
TWD 5B
Long Term Liabilities
TWD 3B
Net Cash
TWD -3.1B
Net Cash By Market Cap
TWD -135
Net Debt EBITDA
TWD 7.75
Net Debt Equity
TWD 1.97
Net Debt FCF
TWD 4.93
Tangible Book Value
TWD 1.5B
Tangible Book Value Per Share
TWD 36.24
WACC
2.86

Liquidity

Current-asset coverage and working-capital efficiency metrics.

6
MetricValue
Current ratio
0.83
Inventory Turnover
3.96
Net Working Capital
TWD -132.5M
Quick ratio
0.28
Working Capital
TWD -464.5M
Working Capital Turnover
TWD -13.18

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

10
MetricValue
Buyback Yield
-0.72%
Dividend Growth
0.08%
Dividend Growth Years
1%
Dividend per share
TWD 3
Dividend Years
14
Dividend Yield
5.57%
Ex Div Date
2025-06-25
Last Dividend
TWD 1.6
Payout Frequency
Annual
Payout Ratio
43.54%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

38
MetricValue
10Y total return
11.28%
1Y total return
-15.58%
200-day SMA
58.43
3Y total return
-51.11%
50-day SMA
54.94
50-day SMA vs 200-day SMA
50under200
5Y total return
-2.01%
All Time High
144.6
All Time High Change
-62.72%
All Time High Date
2023-05-10
All Time Low
35.6
All Time Low Change
51.39%
All Time Low Date
2012-12-21
ATR
0.68
Beta
0.16
Beta1y
0.2
Beta2y
0.16
Ch YTD
-9.11
High
54
High52
68.6
High52 Date
2025-06-02
High52ch
-21.43%
Low
53.9
Low52
51.8
Low52 Date
2026-03-13
Low52ch
4.05%
Ma50ch
-1.9%
Price vs 200-day SMA
-7.75%
RSI
38.77
RSI Monthly
32.64
RSI Weekly
36.2
Sharpe ratio
-1.23x
Sortino ratio
-1.31
Total Return
4.85%
Tr YTD
-9.11
Tr1m
-3.06%
Tr1w
-0.37%
Tr3m
-6.91%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

6
MetricValue
Operating Income
TWD 210.9M
Operating Income Growth
71.36
Operating Income Growth Q
-18.88
Operating Income Growth3 Y
-2.53
Operating Income Growth5 Y
6.84
Operating margin
2.63

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

7
MetricValue
Float
20,745,267%
Net Borrowing
-661,545,000
Shares Insiders
0.31%
Shares Institutions
0.03%
Shares Out
42,323,307
Shares Qo Q
0.93%
Shares Yo Y
0.72%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

65
MetricValue
Adjusted FCF
TWD 614.3M
Average Volume
19,684.35x
Bv Per Share
36.85
CAPEX
TWD -279.4M
Ch10y
-20.48
Ch1m
-3.06
Ch1w
-0.37
Ch1y
-17.71
Ch3m
-6.91
Ch3y
-54.37
Ch5y
-12.79
Ch6m
-6.59
Change
-0.19%
Change From Open
-0.19
Close
54
Days Gap
0
Depreciation Amortization
186,489,000
Dollar Volume
859,974.5
Earnings Date
2026-05-15
EBIT
TWD 210.9M
EBITDA
TWD 397.4M
EPS
TWD 3.64
F Score
7
FCF
TWD 624.5M
FCF EV Yield
11.64x
FCF Per Share
TWD 14.76
Financing CF
-715,108,000
Fiscal Year End
December
Founded
1,990
Goodwill
12,692,000
Graham Number
54.93351
Graham Upside
1.92
Income Tax
TWD 31.2M
Investing CF
-307,492,000
Is Primary Listing
1
Last Earnings Date
2025-11-07
Last Report Date
2025-12-31
Last Split Date
2023-07-20
Last Split Type
Forward
Lynch Fair Value
TWD 26.22
Lynch Upside
-51.35
Ma150
57.24
Ma150ch
-5.84%
Ma20
54.94
Ma20ch
-1.88%
Net CF
-121,662,000
Next Earnings Date
2026-05-15
Open
54
P FCF Ratio
3.65
P OCF Ratio
2.52
Payment Date
2025-07-18
Position In Range
0
Ppne
4,091,874,000
Price Date
2026-05-08
Price EBITDA
TWD 5.74
Ptbv Ratio
1.49
Relative Volume
0.82x
Revenue
8,012,666,000x
SBC By Revenue
0.13x
Share Based Comp
10,202,000
Tax By Revenue
0.39x
Tax Rate
16.72%
Tr6m
-6.59%
Volume
15,955
Z Score
1.47
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

TPEX/4175 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield
+5.6%
$3.00 annual per share
Payout ratio
+43.5%
Share of earnings returned as dividends. Below 60% is generally sustainable.
5Y dividend CAGR
-12.1%
1 consecutive years of growth
Total shareholder yield
+4.8%
Next ex-dividend date: 2025-06-25
Performance

TPEX/4175 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
-15.6%
S&P 500 1Y: n/a
3Y total return
-51.1%
S&P 500 3Y: n/a
5Y total return
-2.0%
S&P 500 5Y: n/a
10Y total return
+11.3%
S&P 500 10Y: n/a
Ownership

Who owns TPEX/4175?

Insider, institutional, and short-interest positioning.

Institutional ownership
+0.0%
Share of float held by funds and institutions
Insider ownership
+0.3%
Stake held by company insiders. Higher generally signals alignment.
Short interest
n/a
Float sold short by bearish positioning
Y/Y dilution
+0.7%
Negative means the company is buying back shares.
Technical

TPEX/4175 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
38.8
Neutral momentum band
Price vs 200-day MA
-7.7%
50/200-day relationship not available
Beta (5Y)
0.16
Less volatile than the market
Sharpe ratio
-1.23
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About TPEX/4175

Hub-level FAQ points readers to the deeper analysis pages.

What is the current tpex/4175 stock rating?

tpex/4175 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full tpex/4175 analysis?

The full report lives at /stocks/tpex/4175/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for tpex/4175?

The latest report frames tpex/4175 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the tpex/4175 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.